HTG Molecular In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More News items for the week of Jan. 3, 2023. HTG Molecular Diagnostics to Raise $10M in Public Offering The firm plans to use the net proceeds from the offering for general corporate purposes including research and development, clinical trials, capital expenditures, and working capital. HTG Molecular Diagnostics to Implement Reverse Stock Split Last month, the company reported a 48 percent year-over-year drop in third quarter revenues as it repositions itself as a developer of drug discovery technologies. Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen The genomic and diagnostics firms posted quarterly financial results late this week. HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure. Aug 26, 2022 People in the News at Gencove, IsoPlexis, HTG Molecular, More Aug 11, 2022 Earnings Roundup: Cytek Biosciences, ProPhase Labs, Applied DNA Sciences, Co-Diagnostics, More Jun 10, 2022 In Brief This Week: T2 Biosystems, HTG, Thermo Fisher, Dante Genomics, OriCiro Genomics, More May 13, 2022 In Brief This Week: Co-Diagnostics, Oxford Nanopore, Prenetics, Dante Labs, Seegene, More Mar 29, 2022 HTG Molecular Diagnostics 2021 Revenues Grow 5 Percent Jan 7, 2022 In Brief This Week: Cue Health, Qiagen, Co-Diagnostics, Vela Diagnostics, Thermo Fisher, HTG, More Jan 6, 2022 HTG Molecular Expects 5 Percent Rise in 2021 Revenues Nov 12, 2021 In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More Aug 12, 2021 HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease Aug 6, 2021 New Products Posted to GenomeWeb: HTG Molecular, Myriad Genetics, Eclipse Bioinnovations, More May 13, 2021 HTG Molecular Diagnostics Q1 Revenues Drop 36 Percent Apr 5, 2021 HTG Molecular Preliminary Q1 Revenues Fall 56 Percent Mar 25, 2021 HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent Jan 5, 2021 HTG Molecular Preliminary 2020 Revenues Drop 56 Percent Nov 23, 2020 HTG Molecular Completes 1-For-15 Reverse Stock Split Nov 11, 2020 HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021 Premium Nov 10, 2020 HTG Molecular Diagnostics Q3 Revenues Drop 67 Percent Aug 13, 2020 BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute Aug 12, 2020 HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures Aug 10, 2020 HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.